178 related articles for article (PubMed ID: 8297526)
1. Immunotherapy of autoimmune disease.
Cooke A; Wraith DC
Curr Opin Immunol; 1993 Dec; 5(6):925-33. PubMed ID: 8297526
[TBL] [Abstract][Full Text] [Related]
2. [Study of autoimmune diseases using animal disease models. 2) Confronting the clinical situation].
Kano K
Nihon Rinsho; 1988 Apr; 46(4):850-9. PubMed ID: 3404707
[No Abstract] [Full Text] [Related]
3. Antigen-based immunotherapy for autoimmune disease: from animal models to humans?
Tian J; Olcott A; Hanssen L; Zekzer D; Kaufman DL
Immunol Today; 1999 Apr; 20(4):190-5. PubMed ID: 10203718
[TBL] [Abstract][Full Text] [Related]
4. Targeted kill: from umbrellas to monoclonal antibodies.
Byers VS; Baldwin RW
J Clin Immunol; 1992 Nov; 12(6):391-405. PubMed ID: 1287032
[No Abstract] [Full Text] [Related]
5. Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases.
Miller A; Hafler DA; Weiner HL
FASEB J; 1991 Aug; 5(11):2560-6. PubMed ID: 1868980
[TBL] [Abstract][Full Text] [Related]
6. [Induction of oral tolerance: a new therapeutic strategy for autoimmune diseases?].
Igaz P
Wien Med Wochenschr; 2000; 150(22):440-3. PubMed ID: 11191953
[TBL] [Abstract][Full Text] [Related]
7. Treatment of autoimmune diseases by oral tolerance to autoantigens.
Weiner HL
Autoimmunity; 1993; 15 Suppl():6-7. PubMed ID: 8218846
[No Abstract] [Full Text] [Related]
8. Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside.
Kuhn C; Weiner HL
Immunotherapy; 2016 Jul; 8(8):889-906. PubMed ID: 27161438
[TBL] [Abstract][Full Text] [Related]
9. T cell targeted immunotherapy for autoimmune disease.
Lee E; Sinha AA
Autoimmunity; 2005 Dec; 38(8):577-96. PubMed ID: 16390811
[TBL] [Abstract][Full Text] [Related]
10. B Cell Modulation Strategies in Autoimmune Diseases: New Concepts.
Musette P; Bouaziz JD
Front Immunol; 2018; 9():622. PubMed ID: 29706952
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?
Peakman M; Dayan CM
Immunology; 2001 Dec; 104(4):361-6. PubMed ID: 11899420
[No Abstract] [Full Text] [Related]
12. The specific immunotherapy of autoimmune diseases through the nanomedicine.
Verdaguer J
Endocrinol Nutr; 2016 Nov; 63(9):437-439. PubMed ID: 27344428
[No Abstract] [Full Text] [Related]
13. Therapy of rat autoimmune disease by a monoclonal antibody specific for T lymphoblasts.
Schluesener H; Brunner C; Vass K; Lassmann H
J Immunol; 1986 Dec; 137(12):3814-20. PubMed ID: 3491149
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of autoimmune diseases.
Boitard C
Klin Wochenschr; 1990; 68 Suppl 21():1-9. PubMed ID: 1973964
[TBL] [Abstract][Full Text] [Related]
15. Antigen recognition and peptide-mediated immunotherapy in autoimmune disease.
Smilek DE; Lock CB; McDevitt HO
Immunol Rev; 1990 Dec; 118():37-71. PubMed ID: 1706681
[No Abstract] [Full Text] [Related]
16. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease.
Miller SD; Turley DM; Podojil JR
Nat Rev Immunol; 2007 Sep; 7(9):665-77. PubMed ID: 17690713
[TBL] [Abstract][Full Text] [Related]
17. T cell receptors in autoimmune disease as targets for immune intervention.
Acha-Orbea H; Steinman L; McDevitt HO
Genome; 1989; 31(2):656-61. PubMed ID: 2483695
[TBL] [Abstract][Full Text] [Related]
18. [One step towards restoration of self-tolerance in human autoimmune diseases].
Chatenoud L
Med Sci (Paris); 2007 Feb; 23(2):167-71. PubMed ID: 17291426
[TBL] [Abstract][Full Text] [Related]
19. CD20: a target antigen for immunotherapy of autoimmune diseases.
Perosa F; Favoino E; Caragnano MA; Prete M; Dammacco F
Autoimmun Rev; 2005 Nov; 4(8):526-31. PubMed ID: 16214090
[TBL] [Abstract][Full Text] [Related]
20. Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity.
Northrup L; Christopher MA; Sullivan BP; Berkland C
Adv Drug Deliv Rev; 2016 Mar; 98():86-98. PubMed ID: 26546466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
